| Line Item | 2023-01-31 | Y/Y |
|---|---|---|
| Revenue | $547.2M | +44.6% |
| Cost of Revenue | $56.6M | +45.4% |
| Gross Profit | $490.7M | +44.5% |
| R&D Expense | $297.2M | +46.3% |
| SG&A Expense | $166.3M | +40.1% |
| Operating Income | -$407.8M | -53.8% |
| Interest Expense | $2.0M | -89.1% |
| Pre-tax Income | -$402.9M | -41.3% |
| Income Tax | $4.9M |
| Line Item | 2023-01-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $526.6M | +119.0% |
| Accounts Receivable | $82.4M | +39.4% |
| Current Assets | $660.4M | +60.5% |
| Total Assets | $955.0M | +35.1% |
| Current Liabilities | $332.3M | +30.2% |
| Total Liabilities | $598.4M | +18.9% |
| Stockholders' Equity | $356.6M | +74.9% |
| Line Item | 2023-01-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$160.1M | -91.0% |
| Capital Expenditures | $5.4M | -87.1% |
| Investing Cash Flow | $64.5M | +134.0% |
| Financing Cash Flow | $381.4M | +925.0% |
| Free Cash Flow | -$165.4M | -31.9% |
| +50.6% |
| Net Income | -$407.8M | -41.4% |
| EPS (Basic) | -$2.04 | -25.2% |
| EPS (Diluted) | -$2.04 | -25.2% |